Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Liminatus Pharma Inc (NASDAQ: LIMN) was $1.58 for the day, down -8.67% from the previous closing price of $1.73. In other words, the price has decreased by -$8.67 from its previous closing price. On the day, 0.49 million shares were traded. LIMN stock price reached its highest trading level at $1.745 during the session, while it also had its lowest trading level at $1.55.
Ratios:
Our analysis of LIMN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.17 and its Current Ratio is at 0.17.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIMN now has a Market Capitalization of 46821816 and an Enterprise Value of 42866400.
Stock Price History:
The Beta on a monthly basis for LIMN is 0.37, which has changed by -0.8034826 over the last 52 weeks, in comparison to a change of 0.15927899 over the same period for the S&P500. Over the past 52 weeks, LIMN has reached a high of $33.66, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -48.41%, while the 200-Day Moving Average is calculated to be -81.50%.
Shares Statistics:
LIMN traded an average of 1.48M shares per day over the past three months and 907030 shares per day over the past ten days. A total of 26.01M shares are outstanding, with a floating share count of 5.56M. Insiders hold about 79.47% of the company’s shares, while institutions hold 0.76% stake in the company. Shares short for LIMN as of 1757894400 were 311749 with a Short Ratio of 0.18, compared to 1755216000 on 273658.
